Straumann (SAUHY) Stock Price, News & Analysis

Company Overview

Straumann Holding AG, trading on the OTC Markets under the ticker SAUHY, is a global leader in restorative and regenerative dentistry. Founded in 1954 and headquartered in Basel, Switzerland, the company develops, manufactures and markets dental implant systems, prosthetic components and biomaterials. Straumann serves dentists, dental laboratories and clinics, offering solutions designed to improve patient outcomes through reliable implant therapy and tissue regeneration.

The company’s core product portfolio includes endosseous implants manufactured from high-performance titanium and ceramic materials, as well as abutments, surgical instruments and patient-specific prosthetic solutions. Straumann has expanded its offerings through strategic acquisitions of brands such as Neodent, Anthogyr and Medentika, enabling a broad range of implant designs and restorative options. In addition, its biomaterials division supplies bone grafts, membranes and sealants to support soft and hard tissue augmentation procedures.

In recent years, Straumann has accelerated its digital dentistry initiatives with intraoral scanners, 3D imaging software and guided surgery platforms. The company also collaborates with orthodontic partners to provide clear aligner therapy under the ClearCorrect brand. Its Research & Development centers in Europe and North America focus on advancing digital workflows, biomaterial science and minimally invasive surgical techniques through ongoing clinical studies and partnerships with academic institutions.

With a presence in over 70 countries, Straumann operates regional subsidiaries across Europe, the Americas, Asia-Pacific and the Middle East. The company’s global distribution network includes direct sales forces and authorized distributors, supporting dental professionals through training programs and digital education portals. As of 2023, Straumann’s executive leadership is headed by Chief Executive Officer Guillaume Daniellot, under whose guidance the company continues to pursue innovation in dental restoration and regenerative therapies.

Key Stats

• Today's Range: $11.39 to $11.67
• 50-Day Range: $11.51 to $13.80
• 52-Week Range: $10.30 to $16.90
• Volume: 236,915 shs
• Average Volume: 162,889 shs
• Market Capitalization: $18.43 billion
• P/E Ratio: N/A
• Dividend Yield: 0.26%
• Price Target: N/A
• Consensus Rating: Strong Buy

SAUHY Stock Analysis - Frequently Asked Questions

How have SAUHY shares performed this year?

Straumann's stock was trading at $12.45 at the start of the year. Since then, SAUHY shares have decreased by 7.2% and is now trading at $11.5587.

When did Straumann's stock split?

Straumann's stock split on Thursday, April 28th 2022.The 5-1 split was announced on Thursday, April 28th 2022. The newly minted shares were distributed to shareholders after the market closes on Thursday, April 28th 2022. An investor that had 100 shares of stock prior to the split would have 500 shares after the split.

How do I buy shares of Straumann?

Shares of SAUHY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 9/03/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: MED/DENTAL - SUPP
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:SAUHY
• Previous Symbol: OTCMKTS:SAUHY
• CIK: 1451279
• Web: www.straumann.com
• Phone: (161) 965-1111
• Fax: 41-61-965-1001
• Employees: 11,815
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 28.90
• P/E Growth: 2.44
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.61
• Quick Ratio: 1.15

Sales & Book Value

• Annual Sales: $2.84 billion
• Price / Sales: 6.48
• Cash Flow: $0.46 per share
• Price / Cash Flow: 25.22
• Book Value: $1.46 per share
• Price / Book: 7.92

Miscellaneous

• Outstanding Shares: 1,594,550,000
• Free Float: N/A
• Market Cap: $18.43 billion
• Optionable: Not Optionable
• Beta: 1.56